Search

for
Search:

GlossaryValganciclovir

antiviral drug treating cytomegalovirus infections in immunocompromised individuals

Valganciclovir is an antiviral medication used to treat infections caused by cytomegalovirus (CMV), particularly in people with weakened immune systems, such as organ transplant recipients or those with HIV/AIDS. It works by inhibiting the replication of the virus, thereby reducing the severity and spread of the infection.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 32 results

research Trichodysplasia of Immunosuppression Treated with Oral Valganciclovir

41 citations, December 2008 in “Journal of the American Academy of Dermatology”

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

research Viral-Associated Trichodysplasia of Immunosuppression

40 citations, August 2010 in “Archives of dermatology”

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

research Trichodysplasia Spinulosa: Rare Presentation of Polyomavirus Infection in Immunocompromised Patients

12 citations, November 2014 in “Journal of Cutaneous Medicine and Surgery”

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

research Leflunomide for the Treatment of Trichodysplasia Spinulosa in a Liver Transplant Recipient

22 citations, March 2017 in “Transplant Infectious Disease”

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

research Dermatoscopy Case of the Month: Trichodysplasia Spinulosa

2 citations, September 2021 in “JAAD case reports”

A man with a weakened immune system was diagnosed with a rare skin condition called trichodysplasia spinulosa using skin examination techniques.

View more "valganciclovir" in research →

Community Join

0 / 0 results

— no results